Role of the immune-kynurenine pathway in treatment-resistant schizophrenia
Wenjin Chen,Yichang Tian,Mengzhuang Gou,Leilei Wang,Jinghui Tong,Yanfang Zhou,Wei Feng,Yanli Li,Song Chen,Yongchang Liu,Zhiren Wang,Shujuan Pan,Ping Zhang,Junchao Huang,Xiaokui Yang,Chiang-Shan R. Li,Li Tian,L. Elliot Hong,Yunlong Tan
DOI: https://doi.org/10.1016/j.pnpbp.2023.110926
IF: 5.201
2023-12-26
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Abstract:Background The immune-inflammatory response system (IRS) and kynurenine pathway (KP) have been implicated in the pathophysiology of schizophrenia. Studies have shown inflammation-related effects on KP metabolism in patients with schizophrenia. This study investigated the relationship between KP metabolites, IRS, and the compensatory immune-regulatory reflex system (CIRS) in patients with treatment-resistant schizophrenia (TRS). Methods Patients with ( n = 53) and without TRS ( n = 47), and healthy controls (HCs, n = 49) were enrolled. We quantified plasma levels of pro-inflammatory cytokines (interleukin [IL]-1β, IL-2, IL-6, soluble( s )IL-6 receptor, IL-8, IL-12, IL-17, IL-18, interferon-γ, and tumor necrosis factor[TNF]-α) and anti-inflammatory cytokines (IL-1 receptor antagonist, IL-4, IL-10, tumor growth factor [TGF]-β1, TGF-β2, soluble (s) IL-2 receptor subunit α, sIL-2 receptor subunit β, and sTNF-α receptor 1) and calculated the IRS/CIRS ratio. We also tested serum metabolites of the KP, including kynurenine (KYN), kynurenic acid (KYNA), and quinolinic acid (QUIN), along with the QUIN/KYNA ratio. Results Patients with TRS had significantly higher IRS/CIRS ratio than non-TRS patients ( p = 0.002) and HCs ( p = 0.007), and significantly lower KYN ( p = 0.001) and KYNA ( p = 0.01) levels than HCs. Binary logistic regression analysis revealed that a younger age at illness onset (odds ratio [ OR ] = 0.91, p = 0.02) and a higher IRS/CIRS ratio ( OR = 1.22; p = 0.007) were risk factors for patients with TRS. After further adjusted for age of onset, the QUIN/KYNA ratio ( β = 0.97; p = 0.02) significantly moderated the relationship between IRS/CIRS and TRS, showing that in the higher QUIN/KYNA condition, higher IRS/CIRS ratio were significantly and more likely to be associated with patients with TRS ( β = 0.12, z = 3.19, p = 0.001), whereas in the low QUIN/KYNA condition, the association between IRS/CIRS ratio and TRS was weak and insignificant. Conclusions The peripheral immune response was imbalanced in TRS and was preferentially directed towards the IRS compared to patients without TRS and healthy controls, which is likely to play a role in neurotoxicity. Additionally, peripheral KP activation was also imbalanced, as evidenced by significantly reduced KYN and KYNA levels in patients with TRS compared to healthy controls, but none of KP metabolisms were significantly difference in non-TRS patients compared to healthy controls. QUIN/KYNA ratio involving to the degree of activation of NMDA receptors, indicated the neurotoxic level of the KP activation. The interaction between IRS/CIRS and QUIN/KYNA ratio was significant in predicting TRS, and our findings suggest a potential role for the immune-kynurenine pathway in TRS pathogenesis.
pharmacology & pharmacy,neurosciences,psychiatry,clinical neurology